Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Steris plc (STE)
NYSE:STE
Holding STE?
Track your performance easily
Earnings Data
Report Date
Feb 05, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
2.32Last Year’s EPS
2.22Same Quarter Last Year
Moderate Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Aug 05, 2019
|% Change Since: -7.62%
|Next Earnings Date:May 13, 2019
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed sentiment with strong revenue growth and earnings per share increases in several segments. However, challenges such as declining margins, specific segment underperformance, and unforeseen losses offset some of the positive metrics.Company Guidance
During the STERIS plc Second Quarter 2025 Earnings Call, the company provided guidance for the fiscal year, highlighting several key metrics. STERIS anticipates a 6% to 7% growth in constant currency organic revenue. Adjusted earnings per diluted share are expected to range between $9.05 and $9.25, with free cash flow projected at approximately $700 million. The company expects capital expenditures of around $360 million for the year. Healthcare segment revenue is anticipated to grow in the mid- to high single digits, driven by strong recurring revenue streams, although healthcare capital equipment revenue may be flat to slightly down due to shipment timing. The Applied Sterilization Technologies (AST) segment is forecasted for high single-digit growth, though exiting the year at double-digit growth is no longer expected. Life Sciences revenue is expected to be flat, with declines in capital equipment offset by consumables' strength. Overall, STERIS maintains confidence in achieving these metrics, supported by strong segment performance and favorable market conditions.Revenue Growth
Total as-reported revenue grew 7% in the second quarter, with constant currency organic revenue also growing 7%.
Earnings Per Share Increase
Adjusted earnings per share from continuing operations were $2.14, representing a 15% increase over last year.
Strong Free Cash Flow
Free cash flow for the first half of fiscal 2025 was $344.5 million, on track with the full year guidance of approximately $700 million.
Healthcare Segment Performance
Healthcare constant currency organic revenue grew 7%, driven by strong recurring revenue streams and market share gains.
AST Segment Growth
Constant currency organic revenue grew 9% in the AST segment, supported by stable global medtech customers and increased bioprocessing demand.
---
STE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
STE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 06, 2024 | $226.92 | $214.93 | -5.28% |
| Aug 06, 2024 | $237.99 | $232.36 | -2.37% |
| May 08, 2024 | $208.56 | $224.34 | +7.57% |
| Feb 07, 2024 | $223.72 | $218.17 | -2.48% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Steris plc (STE) report earnings?
Steris plc (STE) is schdueled to report earning on Feb 05, 2025, TBA Not Confirmed.
What is Steris plc (STE) earnings time?
Steris plc (STE) earnings time is at Feb 05, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is STE EPS forecast?
STE EPS forecast for the fiscal quarter 2025 (Q3) is 2.32.
---
